TMEM97 and Alzheimer disease: The innovative method of measuring mitochondrial axonal velocity as a useful mean to quantify MAM gap width stabilization has provided high precision in identifying modulators of σ1R/σ2R-MAM axis to delay or prevent AD pathogenesis.